SCHEMBL9507945

SCHEMBL9507945

NCC1COc2ccc3ccccc3c2O1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.43
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 1/20 0.41
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HTR1A P08908 4/20 0.40
NFKB1 P19838 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
HTR7 P34969 2/20 0.37
HTR2B P41595 2/20 0.37
TMEM97 Q5BJF2 2/20 0.37
SIGMAR1 Q99720 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9385171 0.88 SLC6A2 (0.41) CYP19A1SLC6A2SLC6A4SLC6A3GAA
SCHEMBL9507937 0.85 CYP19A1 (0.43) CYP19A1GAAL3MBTL1HTR1ANFKB1
SCHEMBL8123944 0.85 CYP19A1 (0.43) CYP19A1GAAL3MBTL1HTR1ANFKB1
Hydrochloric Acid SCHEMBL8131705 0.80 HTR6 (0.47) CYP19A1SLC6A4HTR1ANFKB1NFKB2
SCHEMBL9770197 0.79 TDP1 (0.49) CYP19A1HTR1AALDH1A1SMN1; SMN2
SCHEMBL4538637 0.77 LTA4H (0.40) SLC6A4HTR1AHTTCYP1A2
SCHEMBL3290570 0.75 NFKB1 (0.48) CYP19A1SLC6A2SLC6A4SLC6A3NFKB1
SCHEMBL4197898 0.73 HTR1A (0.55) SLC6A4HTR1AALDH1A1CYP2C19
SCHEMBL4907152 0.73 HTR1A (0.55) SLC6A4HTR1AALDH1A1CYP2C19
SCHEMBL8186813 0.73 ADRA2A (0.60) SLC6A2HTR1AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0564520-A1 USE OF CERTAIN GLUTARIMIDE DERIVATIVES IN THE TREATMENT OF DEPRESSION AND MANIA MERRELL DOW PHARMACEUTICALS INC. (US) 1993-10-13 EP disclosed
WO-1992011011-A1 USE OF CERTAIN GLUTARIMIDE DERIVATIVES IN THE TREATMENT OF DEPRESSION AND MANIA MERRELL DOW PHARMACEUTICALS INC. (US) 1992-07-09 WO disclosed
EP-0492021-A1 Use of certain 1,2-benzoisothiazol-3(2H)-1,1-dioxide derivatives in the treatment of depression and mania MERRELL DOW PHARMACEUTICALS INC. (US) 1992-07-01 EP disclosed